Boston Scientific Corp (BSX) stock
BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3051% below fair value
$44.34+0.14 (+0.32%)
Close on Nov 13, 2026Market cap $64.26BP/E 18.8Yield –
Boston Scientific total assets
Total assets on the balance sheet at the end of each period.
Boston Scientific's total assets was $45.46B at Sep 30, 2026. For fiscal 2025 it was $43.67B, up 10.9% from the year before. Over ten years it grew 9.2% a year on average. The highest annual figure on record is $43.67B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.67B | +10.9% |
| FY2024 | Dec 31, 2024 | $39.40B | +12.1% |
| FY2023 | Dec 31, 2023 | $35.14B | +8.2% |
| FY2022 | Dec 31, 2022 | $32.47B | +0.7% |
| FY2021 | Dec 31, 2021 | $32.23B | +4.7% |
| FY2020 | Dec 31, 2020 | $30.78B | +0.7% |
| FY2019 | Dec 31, 2019 | $30.57B | +45.6% |
| FY2018 | Dec 31, 2018 | $21.00B | +10.3% |
| FY2017 | Dec 31, 2017 | $19.04B | +5.2% |
| FY2016 | Dec 31, 2016 | $18.10B | -0.2% |
| FY2015 | Dec 31, 2015 | $18.13B | +6.5% |
| FY2014 | Dec 31, 2014 | $17.02B | +2.7% |
| FY2013 | Dec 31, 2013 | $16.57B | -3.4% |
| FY2012 | Dec 31, 2012 | $17.15B | -19.4% |
| FY2011 | Dec 31, 2011 | $21.29B | -3.8% |
| FY2010 | Dec 31, 2010 | $22.13B | -12.1% |
| FY2009 | Dec 31, 2009 | $25.18B | -7.2% |
| FY2008 | Dec 31, 2008 | $27.14B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $45.46B | +6.4% |
| Q2 FY2026 | Jun 30, 2026 | $45.22B | +8.8% |
| Q1 FY2026 | Mar 31, 2026 | $44.35B | +10.5% |
| Q4 FY2025 | Dec 31, 2025 | $43.67B | +10.9% |
| Q3 FY2025 | Sep 30, 2025 | $42.71B | +12.2% |
| Q2 FY2025 | Jun 30, 2025 | $41.56B | +12.0% |
| Q1 FY2025 | Mar 31, 2025 | $40.14B | +9.5% |
| Q4 FY2024 | Dec 31, 2024 | $39.40B | +12.1% |
| Q3 FY2024 | Sep 30, 2024 | $38.08B | +11.9% |
| Q2 FY2024 | Jun 30, 2024 | $37.11B | +10.4% |
| Q1 FY2024 | Mar 31, 2024 | $36.67B | +11.5% |
| Q4 FY2023 | Dec 31, 2023 | $35.14B | +8.2% |
| Q3 FY2023 | Sep 30, 2023 | $34.04B | +6.6% |
| Q2 FY2023 | Jun 30, 2023 | $33.60B | +4.4% |
| Q1 FY2023 | Mar 31, 2023 | $32.89B | +1.7% |
| Q4 FY2022 | Dec 31, 2022 | $32.47B | +0.7% |
| Q3 FY2022 | Sep 30, 2022 | $31.95B | +0.2% |
| Q2 FY2022 | Jun 30, 2022 | $32.19B | +3.3% |
| Q1 FY2022 | Mar 31, 2022 | $32.34B | +4.7% |
| Q4 FY2021 | Dec 31, 2021 | $32.23B | +4.7% |
| Q3 FY2021 | Sep 30, 2021 | $31.88B | +3.3% |
| Q2 FY2021 | Jun 30, 2021 | $31.17B | +1.1% |
| Q1 FY2021 | Mar 31, 2021 | $30.90B | +2.6% |
| Q4 FY2020 | Dec 31, 2020 | $30.78B | +0.7% |
| Q3 FY2020 | Sep 30, 2020 | $30.85B | +15.3% |
| Q2 FY2020 | Jun 30, 2020 | $30.82B | +26.8% |
| Q1 FY2020 | Mar 31, 2020 | $30.11B | +26.5% |
| Q4 FY2019 | Dec 31, 2019 | $30.57B | +45.6% |
| Q3 FY2019 | Sep 30, 2019 | $26.76B | +31.3% |
| Q2 FY2019 | Jun 30, 2019 | $24.31B | +23.9% |
| Q1 FY2019 | Mar 31, 2019 | $23.80B | +24.0% |
| Q4 FY2018 | Dec 31, 2018 | $21.00B | +10.3% |
| Q3 FY2018 | Sep 30, 2018 | $20.38B | +9.4% |
| Q2 FY2018 | Jun 30, 2018 | $19.62B | +6.7% |
| Q1 FY2018 | Mar 31, 2018 | $19.20B | +7.0% |
| Q4 FY2017 | Dec 31, 2017 | $19.04B | +5.2% |
| Q3 FY2017 | Sep 30, 2017 | $18.64B | – |
| Q2 FY2017 | Jun 30, 2017 | $18.38B | – |
| Q1 FY2017 | Mar 31, 2017 | $17.94B | – |
| Q4 FY2016 | Dec 31, 2016 | $18.10B | – |
See a number that looks wrong?